Selected research
Industry Research
Gliquidone Industry Research Report 2026
Market perspective
The global Gliquidone market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Gliquidone is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Gliquidone is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Gliquidone is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Gliquidone include Boehringer Ingelheim, Dexa Medica, Menarini Belgium, CR Double-Crane, Jinheng Pharma, Vanguard Pharma, Yiling Pharma and TIPR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Gliquidone market in terms of revenue (US$ million) and, where applicable, sales volume (kg), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kg) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gliquidone Market by Company
Boehringer Ingelheim
Dexa Medica
Menarini Belgium
CR Double-Crane
Jinheng Pharma
Vanguard Pharma
Yiling Pharma
TIPR
Gliquidone Segment by Type
Glequinone Tablets
Glequinone Capsule
Glequinone Sustained Release Tablets
Others
Gliquidone Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Gliquidone Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gliquidone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gliquidone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gliquidone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Gliquidone manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Gliquidone by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Gliquidone in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glequinone Tablets
- Glequinone Capsule
- Glequinone Sustained Release Tablets
- Others
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Boehringer Ingelheim
- Dexa Medica
- Menarini Belgium
- CR Double-Crane
- Jinheng Pharma
- Vanguard Pharma
- Yiling Pharma
- TIPR
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Gliquidone Market Size (2021-2032)
- 2.2.2 Global Gliquidone Sales (2021-2032)
- 2.2.3 Global Gliquidone Market Average Price (2021-2032)
- 2.3 Gliquidone by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Glequinone Tablets
- 2.3.3 Glequinone Capsule
- 2.3.4 Glequinone Sustained Release Tablets
- 2.3.5 Others
- 2.4 Gliquidone by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Retail Pharmacies
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Gliquidone Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Gliquidone Sales (kg) of Manufacturers (2021-2026)
- 3.3 Global Gliquidone Revenue of Manufacturers (2021-2026)
- 3.4 Global Gliquidone Average Price by Manufacturers (2021-2026)
- 3.5 Global Gliquidone Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Gliquidone, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Gliquidone, Product Type & Application
- 3.8 Global Manufacturers of Gliquidone, Established Date
- 3.9 Global Gliquidone Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Boehringer Ingelheim
- 4.1.1 Boehringer Ingelheim Company Information
- 4.1.2 Boehringer Ingelheim Business Overview
- 4.1.3 Boehringer Ingelheim Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Boehringer Ingelheim Gliquidone Product Portfolio
- 4.1.5 Boehringer Ingelheim Recent Developments
- 4.2 Dexa Medica
- 4.2.1 Dexa Medica Company Information
- 4.2.2 Dexa Medica Business Overview
- 4.2.3 Dexa Medica Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Dexa Medica Gliquidone Product Portfolio
- 4.2.5 Dexa Medica Recent Developments
- 4.3 Menarini Belgium
- 4.3.1 Menarini Belgium Company Information
- 4.3.2 Menarini Belgium Business Overview
- 4.3.3 Menarini Belgium Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Menarini Belgium Gliquidone Product Portfolio
- 4.3.5 Menarini Belgium Recent Developments
- 4.4 CR Double-Crane
- 4.4.1 CR Double-Crane Company Information
- 4.4.2 CR Double-Crane Business Overview
- 4.4.3 CR Double-Crane Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 CR Double-Crane Gliquidone Product Portfolio
- 4.4.5 CR Double-Crane Recent Developments
- 4.5 Jinheng Pharma
- 4.5.1 Jinheng Pharma Company Information
- 4.5.2 Jinheng Pharma Business Overview
- 4.5.3 Jinheng Pharma Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jinheng Pharma Gliquidone Product Portfolio
- 4.5.5 Jinheng Pharma Recent Developments
- 4.6 Vanguard Pharma
- 4.6.1 Vanguard Pharma Company Information
- 4.6.2 Vanguard Pharma Business Overview
- 4.6.3 Vanguard Pharma Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Vanguard Pharma Gliquidone Product Portfolio
- 4.6.5 Vanguard Pharma Recent Developments
- 4.7 Yiling Pharma
- 4.7.1 Yiling Pharma Company Information
- 4.7.2 Yiling Pharma Business Overview
- 4.7.3 Yiling Pharma Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Yiling Pharma Gliquidone Product Portfolio
- 4.7.5 Yiling Pharma Recent Developments
- 4.8 TIPR
- 4.8.1 TIPR Company Information
- 4.8.2 TIPR Business Overview
- 4.8.3 TIPR Gliquidone Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 TIPR Gliquidone Product Portfolio
- 4.8.5 TIPR Recent Developments
5 Global Gliquidone Market Scenario by Region
- 5.1 Global Gliquidone Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Gliquidone Sales by Region: 2021-2032
- 5.2.1 Global Gliquidone Sales by Region: 2021-2026
- 5.2.2 Global Gliquidone Sales by Region: 2027-2032
- 5.3 Global Gliquidone Revenue by Region: 2021-2032
- 5.3.1 Global Gliquidone Revenue by Region: 2021-2026
- 5.3.2 Global Gliquidone Revenue by Region: 2027-2032
- 5.4 North America Gliquidone Market Facts & Figures by Country
- 5.4.1 North America Gliquidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Gliquidone Sales by Country (2021-2032)
- 5.4.3 North America Gliquidone Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Gliquidone Market Facts & Figures by Country
- 5.5.1 Europe Gliquidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Gliquidone Sales by Country (2021-2032)
- 5.5.3 Europe Gliquidone Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Gliquidone Market Facts & Figures by Country
- 5.6.1 Asia Pacific Gliquidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Gliquidone Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Gliquidone Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Gliquidone Market Facts & Figures by Country
- 5.7.1 South America Gliquidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Gliquidone Sales by Country (2021-2032)
- 5.7.3 South America Gliquidone Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Gliquidone Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Gliquidone Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Gliquidone Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Gliquidone Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Gliquidone Sales by Type (2021-2032)
- 6.1.1 Global Gliquidone Sales by Type (2021-2032) & (kg)
- 6.1.2 Global Gliquidone Sales Market Share by Type (2021-2032)
- 6.2 Global Gliquidone Revenue by Type (2021-2032)
- 6.2.1 Global Gliquidone Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Gliquidone Revenue Market Share by Type (2021-2032)
- 6.3 Global Gliquidone Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Gliquidone Sales by Application (2021-2032)
- 7.1.1 Global Gliquidone Sales by Application (2021-2032) & (kg)
- 7.1.2 Global Gliquidone Sales Market Share by Application (2021-2032)
- 7.2 Global Gliquidone Revenue by Application (2021-2032)
- 7.2.1 Global Gliquidone Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Gliquidone Revenue Market Share by Application (2021-2032)
- 7.3 Global Gliquidone Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Gliquidone Value Chain Analysis
- 8.1.1 Gliquidone Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Gliquidone Production Mode & Process
- 8.2 Gliquidone Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Gliquidone Distributors
- 8.2.3 Gliquidone Customers
9 Global Gliquidone Analyzing Market Dynamics
- 9.1 Gliquidone Industry Trends
- 9.2 Gliquidone Industry Drivers
- 9.3 Gliquidone Industry Opportunities and Challenges
- 9.4 Gliquidone Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst